Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
15.71
-0.76 (-4.59%)
May 5, 2026, 11:25 AM EDT - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $34.5 million as of May 5, 2026. Its market cap has increased by 306.86% in one year.
Market Cap
34.50M
Enterprise Value
33.53M
1-Year Change
306.86%
Ranking
Category
Stock Price
$15.71
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $34.50M, a decrease of -73.38%. That is a compound annual growth rate of -25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 35.62M | -11.22% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 37.49M |
| Veru Inc. | 36.27M |
| Grace Therapeutics | 36.21M |
| Sensei Biotherapeutics | 36.13M |
| Actinium Pharmaceuticals | 35.23M |
| Boundless Bio | 35.18M |
| Werewolf Therapeutics | 35.14M |
| CervoMed | 34.35M |